The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)
Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[26G-pm]Regulatory sciences (pharmaceuticals, etc.)-1

Sat. Mar 26, 2022 1:30 PM - 2:42 PM JST
Sat. Mar 26, 2022 4:30 AM - 5:42 AM UTC
[Room G] Exhibition Room 212 Bldg. 2: 1F
Chair: Rumiko Hosoki
1:30 PM - 1:42 PM JST(4:30 AM - 4:42 AM UTC)

[26G-pm01S]Regulatory science for an innovative medical material: safety evaluation of Matching Transformation System (MA-T)

○Takahiro Noguchi1, Keisuke Tachibana2, Tsuyoshi Inoue2, Masuo Kondoh2 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ.)
1:42 PM - 1:54 PM JST(4:42 AM - 4:54 AM UTC)

[26G-pm02S]Regulatory science for innovative drug delivery systems: safety and efficacy evaluation of paracellular permeation enhancers

○Sayaka Sugimura1, Keisuke Tachibana2, Masuo Kondoh2 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ.)
1:54 PM - 2:06 PM JST(4:54 AM - 5:06 AM UTC)

[26G-pm03S]Regulatory Science for innovative drug delivery system to the brain: Safety and efficacy evaluation of a claudin-5 modulator in a non-human primate model

○Itsuki Nishino1, Keisuke Tachibana2, Yosuke Hashimoto2, Yumi Iwashita2, Keisuke Shirakura2, Yoshiaki Okada2, Hiroyuki Takeda3, Hiroki Kuniyasu4, Masuo Kondoh2 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. PROS, Ehime. Univ., 4. Grad. Sch. Medic. Sci. Nara Medical Univ.,)
2:06 PM - 2:18 PM JST(5:06 AM - 5:18 AM UTC)

[26G-pm04S]Differences in vaccination against infectious diseases approval judgment for pregnant women by regulatory agencies in each country researched from the package insert, etc.

○Yuusuke Oohashi1, Yumiko Nomura1, Atsuko Okumoto1, Kiyohito Noda2, Shin Okuda2, Junhyun Kim2, Mayumi Shikano1,2 (1. Grad. Sch. Pharm. Sci., Tokyo Univ of Science, 2. Pharm. Sci., Tokyo Univ of Science)
2:18 PM - 2:30 PM JST(5:18 AM - 5:30 AM UTC)

[26G-pm05S]Investigation of the status of Japan’s participation in multi-regional clinical trials and the related factors

○Daisuke Komuta1, Mamoru Narukawa1 (1. School of Pharmacy, Kitasato Univ.)
2:30 PM - 2:42 PM JST(5:30 AM - 5:42 AM UTC)

[26G-pm06S]Study of Adult and Pediatric Simultaneous approval in Japan and the United States

○Hirohito Mori1, Miho Yamamoto1,2, Naoki Matsumaru1, Katsura Tsukamoto1 (1. Gifu Pharm. Univ., 2. Otsuka Pharm.)
Back to Category List